SUMMIT THERAPEUTICS PLC Chart calendar Summit Therapeutics plc
6813770e68802d.7QBuHZNkO_BiW684hlRaEkptDU_2rk1JZ0UeJO3zFwA.i0NZL_YsTLsEY9xL8xIeWC0nPwyRnxp6Fxdqbp-WRHCGUyVX2A5cpgE5mw~ef7063dc3e8686308af4d27af5209dd9
Upcoming events on Summit Therapeutics plc
Past events on Summit Therapeutics plc
| 2024-06-14 09:00 | Annual General Meeting |
| 2024-06-03 08:00 | Business Update Call |
| 2024-05-01 09:00 | Q1 2024 Earnings Call |
| 2024-05-01 07:00 | Q1 2024 Earnings Release |
| 2024-04-16 14:30 | Stifel Virtual Targeted Oncology Days Conference - Fireside Chat |
| 2024-03-22 07:00 | European Lung Cancer Congress - Presentation No 174P |
| 2024-03-22 07:00 | European Lung Cancer Congress - Presentation No 68P |
| 2024-03-12 14:35 | Barclays Global Healthcare Conference |
| 2024-02-20 09:00 | Q4 2023 Earnings Call |
| 2024-02-20 07:00 | Q4 2023 Earnings Release |
| 2024-02-14 14:40 | Oppenheimer Healthcare Life Sciences Conference |
| 2024-01-09 16:30 | JPMorgan Healthcare Conference |
| 2023-11-07 09:00 | Q3 2023 Earnings Call |
| 2023-11-07 07:00 | Q3 2023 Earnings Release |
| 2023-11-04 14:55 | Society for Immunotherapy of Cancer Meeting - Abstract Number.: 1194 |
| 2023-10-11 | Extraordinary Shareholders Meeting |
| 2023-08-09 09:00 | Q2 2023 Earnings Call |
| 2023-08-09 07:00 | Q2 2023 Earnings Release |
| 2023-06-04 09:00 | American Society of Clinical Oncology Meeting - Abstract No 9087 |
| 2023-05-23 13:00 | Annual General Meeting |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2023 | 2024 |
|---|---|---|---|---|---|
|
Net sales Million GBP | Released Forecast Spread | 15,7 15,7 0.1% | 14,5 15,2 -4.37% | 0,00 | 0,00 |
|
EBITDA Million GBP | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 | -138 |
|
EBIT Million GBP | Released Forecast Spread | -25,3 -23,4 -8.21% | -38,3 -43,3 11.45% | 0,00 | -142 |
|
Earnings before Tax (EBT) Million GBP | Released Forecast Spread | -25,6 -21,6 -18.42% | 0,00 0,00 - | 0,00 | 0,00 |
|
Net income Million GBP | Released Forecast Spread | -22,0 -18,5 -18.95% | 0,00 0,00 - | -486 | 0,00 |
|
EPS GBP | Released Forecast Spread | -0,13 -0,12 -13.04% | 0,00 0,00 - | -0,78 | 0,00 |
| Announcement Date | 30/04/20 | 17/03/21 | 20/02/24 | - |
Quarterly results
| Fiscal Period | December | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|
|
Net sales Million GBP | Released Forecast Spread | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBITDA Million GBP | Released Forecast Spread | -35,1 | -34,7 | -34,3 | |||
|
EBIT Million GBP | Released Forecast Spread | -33,9 -31,6 -7% | -35,6 | -36,5 | -36,7 | -40,7 | -43,0 |
| Announcement Date | 01/05/24 | - | - | - | - | - |
More events
Past sector events for Summit Therapeutics plc
| 2024-06-05 03:51 | PHARMAESSENTIA CORPORATION: May 2024 Sales and Revenue Release |
| 2024-05-17 07:00 | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
| 2024-05-16 07:46 | BIOCON LIMITED: Q4 2024 Earnings Release |
| 2024-05-16 01:00 | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
| 2024-05-15 | LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release |
| 2024-05-15 08:05 | THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release |
| 2024-05-15 07:00 | CABALETTA BIO, INC.: Q1 2024 Earnings Release |
| 2024-05-14 | TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release |
| 2024-05-14 16:05 | ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-14 16:00 | ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release |
